Updates are available Correction dated 2019-11-08
Click to view Correction: https://doi.org/10.1038/s41467-019-13095-4
-
Authors
Sim, Wen Jing
Iyengar, Prasanna Vasudevan https://orcid.org/0000-0002-6495-137X
Lama, Dilraj
Lui, Sarah Kit Leng
Ng, Hsien Chun
Haviv-Shapira, Lior
Domany, Eytan
Kappei, Dennis https://orcid.org/0000-0002-3582-2253
Tan, Tuan Zea https://orcid.org/0000-0001-6624-1593
Saei, Azad https://orcid.org/0000-0002-1000-2953
Jaynes, Patrick William
Verma, Chandra Shekhar
Kumar, Alan Prem https://orcid.org/0000-0002-3754-5712
Rouanne, Mathieu
Ha, Hong Koo
Radulescu, Camelia
ten Dijke, Peter
Eichhorn, Pieter Johan Adam https://orcid.org/0000-0001-5840-943X
Thiery, Jean Paul https://orcid.org/0000-0003-0478-5020
- License Information
-
More Information
Article History
Received: 22 December 2017
Accepted: 27 August 2019
First Online: 25 September 2019
Change Date: 8 November 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: C.S.V. is the founder of Sinopsee Therapeutics, a biotech company developing molecules for therapeutic purposes; the current work has no conflict with the company. J.P.T is a consultant/advisory board member for Aim Biotech Singapore, ACT Genomic Taipei, Biosyngen PTE ltd and CSO of BioCheetah Ltd Singapore. The authors declare no further conflicts of interest.
